Beijing Hotgen Biotech Co. Ltd.SSE: 688068

Announcement on Preliminary Earnings Estimate for 2025

Feb 27, 2026 · Issued by Beijing Hotgen Biotech Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Feb 27, 2026

On 6ix: 6ix.com/news/announcement-on-preliminary-earnings-estimate-for-2025-410

Announcement on Preliminary Earnings Estimate for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Beijing Hotgen Biotech Co. Ltd. on 6ix

Earlier from Beijing Hotgen Biotech

Earnings Preannouncement for 2025Jan 17
Announcement on Plan to Sell Part of Repurchased Shares through Call Auction TransactionsDec 24, 2025
Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025Dec 18, 2025
Announcement on Voluntary Disclosure of Recent Qualifications Obtained by the Joint-stock Company of the CompanyDec 3, 2025
Announcement on Joint Investment in Yaojing Gene with a Related Party and Related Party TransactionDec 2, 2025

Later from Beijing Hotgen Biotech

Announcement on Voluntary Disclosure of the Completion of First Patient Enrollment and Dosing in the Phase Ib Clinical Trial of Innovative Drug AA001 Monoclonal Antibody for Alzheimer’s Disease by an Joint-stock CompanyMar 3
Announcement on Voluntary Disclosure of Completion of the First Patient Enrollment and Dosing in the Phase II Clinical Trial of SGC001 Innovative Drug by a SubsidiaryMar 11
Announcement on Initial Sale of Repurchased Shares Through Call AuctionApr 1
Announcement on Progress in Disposal of Repurchased SharesApr 3
Announcement on Voluntary Disclosure of Obtaining the "Acceptance Notice" for Clinical Trial Application for Subsidiary’s Innovative Drug SGT003 InjectionApr 11

All Beijing Hotgen Biotech news releases

Follow Beijing Hotgen Biotech into a list and get an email when it puts out news.

Follow Beijing Hotgen Biotech